Alk Phosphorylates Smad4 On Tyrosine To Disable Tgf-Beta Tumour Suppressor Functions (Vol 21, Pg 179, 2019)

Q Zhang,M Xiao,S Gu,Y Xu,T Liu,H Li,Y Yu,L Qin,Y Zhu,F Chen

DOI: https://doi.org/10.1038/s41556-021-00638-5

IF: 21.3

2021-01-01

Nature Cell Biology

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41556-021-00638-5.

What problem does this paper attempt to address?

Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions

Qianting Zhang,Mu Xiao,Shuchen Gu,Yongxian Xu,Ting Liu,Hao Li,Yi Yu,Lan Qin,Yezhang Zhu,Fenfang Chen,Yulong Wang,Chen Ding,Hongxing Wu,Hongbin Ji,Zhe Chen,Youli Zu,Stephen Malkoski,Yi Li,Tingbo Liang,Junfang Ji,Jun Qin,Pinglong Xu,Bin Zhao,Li Shen,Xia Lin,Xin-Hua Feng

DOI: https://doi.org/10.1038/s41556-021-00638-5

IF: 21.3

2021-01-01

Nature Cell Biology

Abstract:Correction to this paper has been published: https://doi.org/10.1038/s41556-021-00638-5.
Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

G Wang,Y Yu,C Sun,T Liu,T Liang,L Zhan,X Lin,X-H Feng

DOI: https://doi.org/10.1038/onc.2016.145

IF: 8.756

2016-01-01

Oncogene

Abstract:Correction to: Oncogene (2015) 00, 1–11; doi:10.1038/onc.2015.446; published online 30 November 2015 Following the online publication of this article, it was noted that the final word ‘signalling’ had been erroneously missed off the title. The title has now been rectified. The authors apologise for any inconvenience caused by this error.
Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

Sujin Shi,Dewei Xu,Shuchen Gu,Ningyi Xu,Pinglong Xu,Jin Cao,Xin-Hua Feng

2022-01-01

American journal of cancer research

Abstract:Transforming Growth Factor beta (TGF-beta) is a multifunctional cytokine that regulates cell proliferation, differentiation, and apoptosis. Dysregulation of the TGF-beta signaling is one of the major mechanisms underlying tumor progression. We have previously reported that anaplastic lymphoma kinase (ALK) phosphorylates Smad4 at Tyr95, which compromises the DNA-binding ability of Smad4 and thus renders ALK-positive cancer cells resistant to TGF-beta tumor-suppressive action. In this study, we demonstrated that tyrosine phosphatase PTPN2 positively regulated TGF-beta signaling through dephosphorylating Smad4 at the Tyr95 site. Both in vitro and cell-based assays revealed that PTPN2 bound to and dephosphorylated Smad4, thereby preserving the DNA-binding ability of Smad4. Furthermore, overexpression of PTPN2 restored TGF-beta transcriptional and growth inhibitory responses in ALK-positive cancer cells. Consistently, Spermidine, an activator of PTPN2, also promoted TGF-beta-induced gene expression, apoptosis, and anti-proliferation effect. Taken together, we revealed that PTPN2 functioned as a tumor suppressor to antagonize the inhibitory effect of tyrosine phosphorylation of Smad4 and to ensure the proper TGF-beta growth inhibitory signaling in cancer cells.
Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635

Yuying Yao,Zijun Zhou,Liuyou Li,Junchen Li,Lixun Huang,Jiangchao Li,Cuiling Qi,Lingyun Zheng,Lijing Wang,Qian-Qian Zhang

DOI: https://doi.org/10.3390/cells9081918

IF: 6

2020-08-18

Cells

Abstract:The author wishes to make the following correction to this paper [...]

cell biology
Smad4 Sequestered in SFPQ Condensates Prevents TGF-β Tumor-Suppressive Signaling.

Mu Xiao,Fei Wang,Nuo Chen,Hanchenxi Zhang,Jin Cao,Yi Yu,Bin Zhao,Junfang Ji,Pinglong Xu,Lei Li,Li Shen,Xia Lin,Xin-Hua Feng

DOI: https://doi.org/10.1016/j.devcel.2023.11.020

IF: 13.417

2024-01-01

Developmental Cell

Abstract:Loss of TGF-β growth-inhibitory responses is a hallmark of human cancer. However, the molecular mechanisms underlying the TGF-β resistance of cancer cells remain to be fully elucidated. Splicing factor proline- and glutamine-rich (SFPQ) is a prion-like RNA-binding protein that is frequently upregulated in human cancers. In this study, we identified SFPQ as a potent suppressor of TGF-β signaling. The ability of SFPQ to suppress TGF-β responses depends on its prion-like domain (PrLD) that drives liquid-liquid phase separation (LLPS). Mechanistically, SFPQ physically restrained Smad4 in its condensates, which excluded Smad4 from the Smad complex and chromatin occupancy and thus functionally dampened Smad-dependent transcriptional responses. Accordingly, SFPQ deficiency or loss of phase separation activities rendered human cells hypersensitive to TGF-β responses. Together, our data identify an important function of SFPQ through LLPS that suppresses Smad transcriptional activation and TGF-β tumor-suppressive activity.
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Zi Wang,Bianying Ma,Hui Li,Xiaojuan Xiao,Weihua Zhou,Feng Liu,Bin Zhang,M. Zhu,Qin Yang,Yayue Zeng,Yang Sun,Shuming Sun,Yanpeng Wang,Yibin Zhang,Haibo Weng,Lixiang Chen,Mao Ye,X. An,Jing Liu

DOI: https://doi.org/10.18632/oncotarget.27282

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.6312.].
Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Wenjia Liu,Liqiang Zhang,Kun Xuan,Chenghu Hu,Liya Li,Yongjie Zhang,Fang Jin,Yan Jin

DOI: https://doi.org/10.7150/thno.103686

IF: 11.6

2024-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.27372.].
Correction: A Novel Highly Potent Trivalent TGF-β Receptor Trap Inhibits Early-Stage Tumorigenesis and Tumor Cell Invasion in Murine Pten-deficient Prostate Glands

Tai Qin,Lindsey Barron,Lu Xia,Haojie Huang,Maria M. Villarreal,John Zwaagstra,Cathy Collins,Junhua Yang,Christian Zwieb,Ravindra Kodali,Cynthia S. Hinck,Sun Kyung Kim,Robert L. Reddick,Chang Shu,Maureen D. O'Connor-McCourt,Andrew P. Hinck,Lu-Zhe Sun

DOI: https://doi.org/10.18632/oncotarget.13343

2016-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.13343.].
EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Chen Yi,Xiliu Zhang,Hongyu Li,Guanhui Chen,Binghui Zeng,Yiming Li,Chao Wang,Yi He,Xun Chen,Zixian Huang,Dongsheng Yu

DOI: https://doi.org/10.7150/jca.87278

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.59331.].

oncology
Correction: Wang et al. TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis. Biology 2022, 11, 141

Yanbing Wang,Yiwu Chen,Chang Li,Zhiwei Xiao,Hongming Yuan,Yuanzhu Zhang,Daxin Pang,Xiaochun Tang,Mengjing Li,Hongsheng Ouyang

DOI: https://doi.org/10.3390/biology11101400

2022-09-26

Abstract:The authors would like to make the following correction to the published paper [...].
Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

Yunfu Deng,Guangzhi Ma,Karin A. Vallega,Dongsheng Wang,Mingliang Wang,Changwei Wang,Shaomeng Wang,Suresh S. Ramalingam,Shi-Yong Sun

DOI: https://doi.org/10.1038/s41417-022-00479-w

IF: 5.854

2022-05-10

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 10 May 2022; doi:10.1038/s41417-022-00479-w Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Erratum: Smad3 and Smad4 Cooperate with C-Jun/c-fos to Mediate TFG-β-induced Transcription

Zhang, Ying,Feng, Xin-Hua,Derynck, Rik

DOI: https://doi.org/10.1038/24911

IF: 64.8

1998-01-01

Nature

Abstract:Nature 394 909–913 (1998) In Fig. 1 of this Letter, the key in all panels was incorrect: black bars should be +TGF-β, and white bars should be −TGF-β; in addition, the c-Fos Smad3/4 bar colours were transposed in panel b. The correct figure is shown here. In Fig. 3f, right panel, the symbols should all have been plus signs, as shown here.
Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

Chen-Chen Huang,Fang-Rui Liu,Qiang Feng,Xin-Yan Pan,Shu-Ling Song,Ju-Lun Yang

DOI: https://doi.org/10.1186/s12885-021-08120-z

IF: 4.638

2021-04-07

BMC Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: CRL4DCAF4 E3 ligase-mediated degradation of MEN1 transcriptionally reactivates hTERT to sustain immortalization in colorectal cancer cells

DOI: https://doi.org/10.1093/carcin/bgae039

2024-06-12

Carcinogenesis

Abstract:This is a correction to: Zhimin Ao, Dan Xiao, Jing Wu, Ji Sun, Hong Liu, CRL4 DCAF4 E3 ligase-mediated degradation of MEN1 transcriptionally reactivates hTERT to sustain immortalization in colorectal cancer cells, Carcinogenesis , 2024;, bgae024, https://doi.org/10.1093/carcin/bgae024.

oncology
Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Lili Li,Juan Xu,Guohua Qiu,Jianming Ying,Zhenfang Du,Tingxiu Xiang,Kai Yau Wong,Gopesh Srivastava,Xiao-Feng Zhu,Tony S Mok,Anthony Tc Chan,Francis Kl Chan,Richard F Ambinder,Qian Tao

DOI: https://doi.org/10.7150/thno.70351

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.20893.].
Erratum: Correction: Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway (The Journal of biological chemistry (2019) 294 17 (7037-7045))

Bo Peng,Janice Ortega,Liya Gu,Zhijie Chang,Guo Min Li

DOI: https://doi.org/10.1074/JBC.AAC120.014866

IF: 5.485

2020-01-01

Journal of Biological Chemistry

Abstract:VOLUME 294 (2019) PAGES 7037–7045 The affiliation for the corresponding author was missing information. The correct footnote should read as follows. Holder of a CPRIT Scholar in Cancer Research and the Reece A. Overcash, Jr. Chair for Research on Colon Cancer. To whom correspondence should be addressed. Tel.: 214-648-9955; Fax: 214-648-5995; E-mail: [email protected] .
Correction: Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial–mesenchymal transition

Yao Su,Xueying Wang,Zhen Guo,Jun Wang

DOI: https://doi.org/10.1038/s41388-021-01643-6

IF: 8.756

2021-03-26

Oncogene

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41388-021-01643-6

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Erratum: Increased expression of latent TGF- β -binding protein 4 affects the fibrotic process in scleroderma by TGF- β /SMAD signaling

Jiaying Lu,Qingmei Liu,Lei Wang,Wenzhen Tu,Haiyan Chu,Weifeng Ding,Shuai Jiang,Yanyun Ma,Xiangguang Shi,Weilin Pu,Xiaodong Zhou,Li Jin,Jiucun Wang,Wenyu Wu

DOI: https://doi.org/10.1038/labinvest.2017.43

IF: 5.511

2017-01-01

Laboratory Investigation

Abstract:Correction to: Laboratory Investigation advance online publication, 6 March 2017; doi:10.1038/labinvest.2017.20 In this paper, the affiliation of Dr Wenya Wu should be only Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Correction: Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells

Wenjia Liu,Liqiang Zhang,Kun Xuan,Chenghu Hu,Shiyu Liu,Li Liao,Bei Li,Fang Jin,Songtao Shi,Yan Jin

DOI: https://doi.org/10.1038/s41413-020-00107-z

IF: 12.7

2020-07-28

Bone Research

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

cell & tissue engineering
Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells.

Wei Huang,Xia Yuan,Ting Sun,Shujie Fan,Jun Wang,Quan Zhou,Wei Guo,Fuxiang Ran,Zemei Ge,Huayu Yang,Runtao Li,Jingrong Cui

DOI: https://doi.org/10.3389/fphar.2024.1418274

IF: 5.6

2024-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2017.00476.].

Alk Phosphorylates Smad4 On Tyrosine To Disable Tgf-Beta Tumour Suppressor Functions (Vol 21, Pg 179, 2019)

Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635

Smad4 Sequestered in SFPQ Condensates Prevents TGF-β Tumor-Suppressive Signaling.

Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Correction: A Novel Highly Potent Trivalent TGF-β Receptor Trap Inhibits Early-Stage Tumorigenesis and Tumor Cell Invasion in Murine Pten-deficient Prostate Glands

EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Correction: Wang et al. TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis. Biology 2022, 11, 141

Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

Erratum: Smad3 and Smad4 Cooperate with C-Jun/c-fos to Mediate TFG-β-induced Transcription

Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

Correction to: CRL4DCAF4 E3 ligase-mediated degradation of MEN1 transcriptionally reactivates hTERT to sustain immortalization in colorectal cancer cells

Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Erratum: Correction: Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway (The Journal of biological chemistry (2019) 294 17 (7037-7045))

Correction: Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial–mesenchymal transition

Erratum: Increased expression of latent TGF- β -binding protein 4 affects the fibrotic process in scleroderma by TGF- β /SMAD signaling

Correction: Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells

Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells.